A Study of E6011 in Participants With Active Crohn's Disease

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

NCT01751152 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

NCT01277666 ·Status: COMPLETED ·Phase: PHASE3

A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease

NCT00445939 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease

NCT00573469 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease

NCT03992469 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

NCT02367183 ·Status: COMPLETED ·Phase: PHASE1

Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

NCT03395184 ·Status: COMPLETED ·Phase: PHASE2

A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease

NCT00445432 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

NCT02877134 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease

NCT03808103 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease

NCT02394028 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease

NCT02048618 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

NCT03677648 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease

NCT00291668 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

NCT00032799 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects

NCT01221818 ·Status: COMPLETED ·Phase: PHASE1

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease

NCT01276509 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

NCT04151225 ·Status: WITHDRAWN ·Phase: PHASE2

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

NCT06023030 ·Status: RECRUITING

A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease

NCT00078611 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating ERB-041 in Active Crohn's Disease

NCT00245947 ·Status: COMPLETED ·Phase: PHASE1

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

NCT04706793 ·Status: COMPLETED ·Phase: PHASE3

Special Investigation in Patients With Crohn's Disease (All Patients Investigation)

NCT01298648 ·Status: COMPLETED

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

NCT06819878 ·Status: RECRUITING ·Phase: PHASE3

Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon

NCT00348283 ·Status: COMPLETED ·Phase: PHASE3